ASK PHARM(SZ:002755) Xin Lang Cai Jing·2025-11-12 02:16Core Viewpoint - The stock of Aosaikang has shown a significant increase of 51.47% year-to-date, with recent trading activity indicating a mixed performance in the short term [1][2]. Group 1: Stock Performance - As of November 12, Aosaikang's stock price rose by 2.03% to 19.07 CNY per share, with a trading volume of 57.05 million CNY and a turnover rate of 0.33%, resulting in a total market capitalization of 17.7 billion CNY [1]. - Year-to-date, Aosaikang's stock has increased by 51.47%, with a slight rise of 0.10% over the last five trading days, a decline of 1.60% over the last 20 days, and a significant drop of 27.02% over the last 60 days [1]. - The company has appeared on the "龙虎榜" (a list of stocks with significant trading activity) twice this year, with the most recent occurrence on July 16 [1]. Group 2: Financial Performance - For the period from January to September 2025, Aosaikang reported a revenue of 1.434 billion CNY, reflecting a year-on-year growth of 3.57%, while the net profit attributable to shareholders increased by 75.81% to 223 million CNY [2]. - Since its A-share listing, Aosaikang has distributed a total of 721 million CNY in dividends, with 111 million CNY distributed over the past three years [3]. Group 3: Shareholder Information - As of October 20, Aosaikang had 27,500 shareholders, an increase of 1.09% from the previous period, with an average of 33,706 circulating shares per shareholder, a decrease of 1.08% [2]. - Among the top ten circulating shareholders, notable changes include an increase in holdings by Yongying Medical Innovation Mixed Fund and the entry of new shareholders such as Yongying Ruixin Mixed Fund and Yongying Stable Enhanced Bond Fund [3].